Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections.

Abstract

Acute bacterial respiratory infections (ABRIs) require treatment with antibiotics. Although antibiotics may address the underlying pathogenic factors, over-the-counter (OTC) agents can play an adjuvant role in relieving mucus-related symptoms. This complimentary role contributes to the healing process and is supported by current clinical guidelines.

• Authors: George Kikano
• Journal: Postgraduate medicine (Postgrad Med) Vol. 121 Issue 3 Pg. 173-5 (May 2009) ISSN: 1941-9260 [Electronic] England
• PMID: 19491556 (Publication Type: Comment, Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Delayed-Action Preparations
• Drug Combinations
• Expectorants
• Nasal Decongestants
• Guaifenesin
• Pseudoephedrine

Topics

• Acute Disease
• Administration, Oral
• Adolescent
• Adult
• Aged
• Delayed-Action Preparations
• Diagnosis, Differential
• Dose-Response Relationship, Drug
• Drug Combinations
• Expectorants (administration & dosage)
• Female
• Follow-Up Studies
• Guaifenesin (administration & dosage)
• Humans
• Male
• Middle Aged
• Nasal Decongestants (administration & dosage)
• Pseudoephedrine (administration & dosage)
• Respiratory Tract Infections (diagnosis, drug therapy)
• Time Factors
• Treatment Outcome
• Young Adult